BROOKFIELD, Wisconsin, May 13 /PRNewswire/ -- NetEconomy, the global leader in financial crime management and compliance solutions and a business unit of Fiserv, Inc. (NASDAQ: FISV), today announced that IBS Publishing has ranked NetEconomy as the top-selling provider of global anti-money laundering (AML) solutions. IBS determined the ranking by analyzing the AML market for the number of new name wins achieved in 2007.

"NetEconomy has had an exceptional year, leading the way with 38 new customer wins in the United States and Western Europe, putting it ahead of the rest of the field," said James Ling, sales league table editor of IBS.

REDMOND, Washington, May 13 /PRNewswire/ --

- New elements include platform updates and product road map for developers.

LONDON, May 13 /PRNewswire/ --

- Application Connects Mobile, Online Communities, Social Networks - All in One Place

Nimbuzz (http://www.nimbuzz.com) today announces the UK launch of an application to provide mobile users and online communities with "free calls, chat and more." Nimbuzz offers an all-in-one solution for free mobile VoIP calling, conference calling, instant messaging, chat and group chat, and photo and file sending across multiple IM communities, including Skype, MSN, Google Talk, Yahoo!, AIM, Jabber and ICQ, plus 23 social networks, including Facebook and Myspace.

A new study released today in the online edition of Physiological Genomics finds that individuals with a specific genetic variation consistently consume more sugary foods. The study offers the first evidence of the role that a variation in the GLUT2 gene – a gene that controls sugar entry into the cells – has on sugar intake, and may help explain individual preferences for foods high in sugar.

Summary of the Study

Food preferences are influenced by the environment as well as genetics. Cravings for foods high in sugar vary from person to person, but the reasons why are still unclear. To better understand the mechanism, the research team examined the effect of a common variation in a gene that controls the entry of sugar (glucose) into cells.

NEW YORK, May 13 /PRNewswire/ --

- Separate Editions Deliver Specialized Pre-Market Content to Corporate Bond, Eurobond & Emerging Market Professionals Who Use the MarketAxess Trading Platform or Corporate BondTicker(TM) Service

LONDON, May 13 /PRNewswire/ --

Chiltern, a leading global research organization, announced that it has opened a new office in Lisbon, Portugal. Mr. Ricardo Diaz will head Chiltern's new office as Country Manager. Mr. Diaz has over 10 years experience in clinical research and holds a Master's Degree in Pharmacology, a Master's in Clinical trials and an MBA.

The office is staffed with highly qualified clinical research professionals, supporting Chiltern's on-going clinical studies in Portugal. Additionally, our Resourcing Solutions brand provides local sponsors with the opportunity to bring on board well-trained personnel, based at either clinical sites or the sponsors' offices, on short or long-term contracts.

ISTANBUL, Turkey, May 13 /PRNewswire/ --

- Japanese Pharmaceutical Company Establishes its own Turkish Subsidiary

- Important Step in Global Expansion

DAIICHI SANKYO, one of the world's leading research-driven pharmaceutical companies based in Japan, is establishing its own subsidiary in Turkey. The company, to be called DAIICHI SANKYO Ilaç Tikaret Ltd., will be headquartered in Istanbul and will initially focus on marketing the osteoporosis medication Evista (Raloxifen).

Long-term harmful effects of marijuana include risk for heart attacks and strokes in addition to impaired learning and memory.

The active chemical in marijuana, called delta-9-tetrahyrdocannabinol (THC), is believed to exert these effects by binding to cannabinoid (CB) receptors located on several cell types in various organs.

Scientists have found CB receptors in many organs including the brain, heart, liver, kidney, and spleen. In this study, researchers investigated if persistent heavy marijuana use might be associated with changes in different blood proteins in order to check if the abnormalities in the identified proteins might be related to other side-effects of marijuana.

SAN FRANCISCO, May 13 /PRNewswire/ --

WeatherBill (www.weatherbill.com) today announced that Jens Boening, a weather risk management industry leader, has been appointed as Managing Director, Europe and Asia for the company. Boening will be based out of WeatherBill's new United Kingdom branch office, and will be positioned to better serve the needs of WeatherBill's rapidly growing European and Asian client base of weather-sensitive companies. Boening will report directly to WeatherBill's CEO and Founder David Friedberg.

NEW YORK, May 13 /PRNewswire/ --

Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research by an independent selection committee of world-renowned scientists.